Filippo de Braud, MD, is currently Full Professor of Medical Oncology and Director of the School of Specialization in Medical Oncology, Università degli Studi di Milano, Italy and Director of Medical Oncology Division of the Istituto Nazionale dei Tumori, Milan, where his principal area of expertise is clinical research in oncology.
In 1984, Prof. de Braud received his medical degree in medicine from the University of Milan and continued his training in oncology at various institutions, including the Royal Free Hospital School of Medicine, London, UK, the Wayne State University, Detroit, MI, USA., and the Institute Gustave Roussy , Paris, FR. He has held clinical posts at the European Institute of Oncology, where he was appointed Deputy Director of the Medical Oncology Division in 1994, later becoming Director of Division of Clinical Pharmacology and New Drugs Development since August 2011 when he was appointed as Chief of Division of Medical Oncology at National Cancer Institute, Milan.
He leads researchers in new drugs development (Phase I and early Phase II studies) and teaches medical oncology as full professor at Università degli Studi di Milano.
Since 2000, he has been appointed Scientific Advisor and Member of Committee at Italian Medicine Agency AIFA, Ministry of Health, and several Pharmaceutical Companies.
Prof. de Braud is the author or coauthor of over 600 publications in medical oncology, Scopus: 73 h-index.